Man Group
TEVA icon

Man Group’s Teva Pharmaceuticals TEVA Stock Holding History

Man Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Sell
9,014
-3,416
-27% -$114K ﹤0.01% 2169
2026
Q1 		$374K Sell
12,430
-31,539
-72% -$1.01M ﹤0.01% 2155
2025
Q4 		$1.37M Buy
43,969
+4,669
+12% +$115K ﹤0.01% 1589
2025
Q3 		$794K Buy
+39,300
New +$690K ﹤0.01% 1746
2025
Q2 		– Sell
-110,568
Closed -$1.7M – 2384
2025
Q1 		$1.7M Buy
110,568
+67,266
+155% +$1.2M ﹤0.01% 1423
2024
Q4 		$954K Buy
43,302
+28,457
+192% +$518K ﹤0.01% 1496
2024
Q3 		$268K Sell
14,845
-17,344
-54% -$304K ﹤0.01% 1791
2024
Q2 		$523K Buy
+32,189
New +$496K ﹤0.01% 1675
2023
Q3 		– Sell
-1,200,400
Closed -$9.04M – 2142
2023
Q2 		$9.04M Buy
+1,200,400
New +$9.73M 0.03% 653
2022
Q2 		– Hold
0
– – – 1735
2021
Q2 		– Sell
-18,500
Closed -$213K – 2097
2021
Q1 		$213K Buy
+18,500
New +$212K ﹤0.01% 1739
2018
Q4 		– Sell
-4,300
Closed -$93K – 2108
2018
Q3 		$93K Sell
4,300
-14,428
-77% -$335K ﹤0.01% 2050
2018
Q2 		$455K Buy
+18,728
New +$382K ﹤0.01% 1833

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Man Group's TEVA Position: Q2 2026 in Review

Man Group reduced its Teva Pharmaceuticals (TEVA) stake by 27% in Q2 2026, selling an estimated $114K and leaving 9,014 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Man Group first reported a position in TEVA in Q2 2018 and has held it in 12 quarters since. The position peaked at $9.04M in Q2 2023. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Man Group held 9,014 shares of Teva Pharmaceuticals worth $305K as of Q2 2026.
  • Man Group sold 3,416 Teva Pharmaceuticals shares in Q2 2026, an estimated $114K.
  • Teva Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2169 holding.
  • Man Group first reported a position in Teva Pharmaceuticals in Q2 2018 and has held it in 12 quarters since.
  • Man Group's Teva Pharmaceuticals position peaked at $9.04M in Q2 2023.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.